Hence, future endeavors will necessitate the experimental validation of pertinent signaling pathways, aiming to further elucidate the functional roles of IKBKE and HSPA1A and to investigate their specific implications in the therapeutic management of AD and LIHC. Here, HSPA1A is linked to Alzheimer disease.